All lobbying filings

AVIVA STRATEGIES (FKA MGB CONSULTING)

AVIVA STRATEGIES (FKA MGB CONSULTING) filed a Q3 report for ACT FOR ULTRA RARE on October 19, 2026, reporting $37,500 in lobbying income.

Lobbying for ACT FOR ULTRA RARE · Advocacy for ultra rare disease

All filings by AVIVA STRATEGIES (FKA MGB CONSULTING) · Everything ACT FOR ULTRA RARE has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$37,500

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Ultra rare disease advocacy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.